Current developments in neurology, part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis

Barry E. Gidal, Mary L. Wagner, Michael D. Privitera, Christina Dalmady-Israel, M. Lynn Crismon, Susan C. Fagan, Nina M. Graves

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

When caring for patients with disorders of the central nervous system such as migraine headaches, epilepsy, or MS, clinicians are faced with increasingly complex pharmacotherapeutic options. Pharmacotherapeutic strategies directed toward prevention, reversal, or cure of these diseases are hampered by an incomplete understanding of the underlying pathophysiology. In this decade of the brain, basic science research combined with difficult but necessary clinical trials may answer some seemingly overwhelming questions for these devastating illnesses.

Original languageEnglish (US)
Pages (from-to)1272-1276
Number of pages5
JournalAnnals of Pharmacotherapy
Volume30
Issue number11
DOIs
StatePublished - Nov 1996

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Current developments in neurology, part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis'. Together they form a unique fingerprint.

Cite this